T3011

AXP000080.1 · Oncolytic virus

Platform
HSV-1 (ICP34.5- ICP47-)
Originator
ImmVira Pharma
Sponsor
ImmVira Pharma

Names

NameTypeSource
T3011preferred name, codecurator, ncit
MVR-T3011codectgov

Virus

Role
Oncolytic
Family
Orthoherpesviridae
Virus
herpes simplex virus 1 (NCBI Taxonomy 10298)
Replication
conditionally replicating
Modifications
ICP34.5 and ICP47 deleted
Transgenes
IL12A, IL12B, anti-PD-1 antibody
Route
intratumoral, intravenous, intra arterial
Source
evidence

Cross-references

NCI Thesaurus
C175473

Approvals

No regulatory approval recorded.

Clinical trials (12)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT06971614A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBCRecruitingPhase 22025-06-092028-12-31160Nonmuscle-invasive Bladder Cancer
NCT05756556T3011 in Combination With Cobimetinib in Patients With Advanced MelanomaSuspendedPhase 22024-06-302026-12-3168Malignant Melanoma; Melanoma
NCT06283303A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal CancerUnknownPhase 12024-04-022025-11-308Colorectal Cancer Metastatic
NCT06214156A Clinical Study of T3011 in Subjects With Advanced MelanomaRecruitingPhase 1/22024-01-262026-09-3042Advanced Melanoma
NCT06214143A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid TumorsRecruitingPhase 1/22024-01-112026-12-3168Advanced Solid Tumors
NCT06200376A Clinical Study of Intraperitoneal T3011 Given as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal CancerUnknownPhase 12023-09-282024-1210Malignant Ascites
NCT06427291Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC PatientsUnknownPhase 12023-09-212025-12-3120Bladder Cancer
NCT06200363A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal CancerUnknownPhase 12023-09-212024-1115Advanced Colorectal Cancer
NCT05598268A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.UnknownPhase 1/22022-03-012024-0674Advanced Solid Tumor; Liver Cancer; Lung Cancer; Lymphoma; Mesothelioma of Pleura
NCT04780217Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid TumorsUnknownPhase 1/22021-08-102025-0342Colorectal Cancer; Endometrial Cancer; Hepatocellular Carcinoma; NSCLC; Ovarian Cancer; Solid Tumor
NCT04370587A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsRecruitingPhase 1/22020-09-172026-09-2230HNSCC; Melanoma; NSCLC; Sarcoma; Solid Tumor; Squamous Cell Carcinoma
NCT05602792A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid TumorsUnknownPhase 1/22020-04-212023-07233Advanced Solid Tumor; Breast Cancer; Esophagus Cancer; HNSCC; NSCLC; Non-melanoma Skin Cancer; Sarcoma

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 41721376First-in-human phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors, including recurrent or metastatic HNSCC.BMC medicine2026cited by trial NCT05602792

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 35836877Advances in the clinical development of oncolytic viruses.American journal of translational research2022name in abstract: T3011
PMID 16517525Determination of acrylamide in foods by pressurized fluid extraction and liquid chromatography-tandem mass spectrometry used for a survey of Spanish cereal-based foods.Food additives and contaminants2006name in abstract: T3011

Notes

Also written MVR-T3011. Dosed intratumorally, intravenously and by hepatic arterial infusion in China, Australia and the US.

How to cite

T3011 (AXP000080.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000080.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.